Cargando…

Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy

BACKGROUND: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complication...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayan, Durmuş, Şeneş, Mehmet, Çaycı, Ayşe Banu, Söylemez, Sibel, Eren, Nezaket, Altuntaş, Yüksel, Öztürk, Feyza Yener
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708292/
https://www.ncbi.nlm.nih.gov/pubmed/31496913
http://dx.doi.org/10.2478/jomb-2019-0014
_version_ 1783445992219082752
author Ayan, Durmuş
Şeneş, Mehmet
Çaycı, Ayşe Banu
Söylemez, Sibel
Eren, Nezaket
Altuntaş, Yüksel
Öztürk, Feyza Yener
author_facet Ayan, Durmuş
Şeneş, Mehmet
Çaycı, Ayşe Banu
Söylemez, Sibel
Eren, Nezaket
Altuntaş, Yüksel
Öztürk, Feyza Yener
author_sort Ayan, Durmuş
collection PubMed
description BACKGROUND: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complications of diabetes. METHODS: Normoalbuminuric type-2 diabetic patients (Group II, n=100), microalbuminuric type 2 diabetic patients (Group III, n=100) and the control group (Group I, n=100) were included in the study. The age and gender of the patient groups matched with the age and gender of the control group. HTLase, PON and ARE enzyme activities were measured by the spectrophotometric method using a g-thiobutyrinolactone, paraoxon, and phenylacetate substrates respectively. In this study, an autoanalyzer application was developed in order to measure HTLase enzyme activity for the first time. RESULTS: Serum HTLase, ARE and PON activities of Group III and Group II were significantly low compared to HTLase, ARE and PON results of Group I (p<0.05). CONCLUSIONS: Based on our results, PON, ARE and HTLase enzyme activities were found to be decreased due to the increase in the degree of DN.
format Online
Article
Text
id pubmed-6708292
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-67082922019-09-06 Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy Ayan, Durmuş Şeneş, Mehmet Çaycı, Ayşe Banu Söylemez, Sibel Eren, Nezaket Altuntaş, Yüksel Öztürk, Feyza Yener J Med Biochem Original Paper BACKGROUND: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complications of diabetes. METHODS: Normoalbuminuric type-2 diabetic patients (Group II, n=100), microalbuminuric type 2 diabetic patients (Group III, n=100) and the control group (Group I, n=100) were included in the study. The age and gender of the patient groups matched with the age and gender of the control group. HTLase, PON and ARE enzyme activities were measured by the spectrophotometric method using a g-thiobutyrinolactone, paraoxon, and phenylacetate substrates respectively. In this study, an autoanalyzer application was developed in order to measure HTLase enzyme activity for the first time. RESULTS: Serum HTLase, ARE and PON activities of Group III and Group II were significantly low compared to HTLase, ARE and PON results of Group I (p<0.05). CONCLUSIONS: Based on our results, PON, ARE and HTLase enzyme activities were found to be decreased due to the increase in the degree of DN. Sciendo 2019-03-26 /pmc/articles/PMC6708292/ /pubmed/31496913 http://dx.doi.org/10.2478/jomb-2019-0014 Text en © 2019 Durmuş Ayan, Mehmet Şeneş, Ayşe Banu Çaycı, Sibel Söylemez, Nezaket Eren, Yüksel Altuntaş, Feyza Yener Öztürk published by sciendo http://creativecommons.org/licenses/by-nc-nd/4.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
spellingShingle Original Paper
Ayan, Durmuş
Şeneş, Mehmet
Çaycı, Ayşe Banu
Söylemez, Sibel
Eren, Nezaket
Altuntaş, Yüksel
Öztürk, Feyza Yener
Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
title Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
title_full Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
title_fullStr Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
title_full_unstemmed Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
title_short Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
title_sort evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708292/
https://www.ncbi.nlm.nih.gov/pubmed/31496913
http://dx.doi.org/10.2478/jomb-2019-0014
work_keys_str_mv AT ayandurmus evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy
AT senesmehmet evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy
AT caycıaysebanu evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy
AT soylemezsibel evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy
AT erennezaket evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy
AT altuntasyuksel evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy
AT ozturkfeyzayener evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy